Imaging Seminar Series with the Center for Alzheimer Research

Seminars spring 2024

Wednesday January 24 from 15.00 - 16.00

Stockholm time zone, online seminar on zoom:

Seminar theme: Quantification of small vessel disease markers

Erin Gibson, Sunnybrook Health Sciences Centre, Kanada
"SynthSegCSVD: Enhanced quantification of key neuroimaging markers of cerebral small vessel disease"

Friday February 23 at 13-14

Linking pathology and brain atrophy

Daniel Kor, University of Oxford, UK
"Understanding the histological basis of MRI"

Niels Reijner, Amsterdam UMC, The Netherlands
"Clinical phenotypes of Alzheimer’s disease: atrophy patterns and their pathological correlates"

Friday March 22 at 13-14

Seminar theme: Machine/deep learning applications in neuroimaging

Evangelos Galaris, Karolinska Institutet
"Identifying spatial patterns of white matter hyperintensities using spectral clustering" 

Farshad Falahati, Karolinska Institutet
"SynthSegCSVD: Enhanced quantification of key neuroimaging markers of cerebral small vessel disease"

Friday April 26 at 13-14

Reaching the hippocampus

Elva Arulchelvan, Trinity College Dublin, Ireland
"Stimulating the hippocampus via a locus coeruleus-noradrenaline (LC-NA) pathway: A peripheral nerve stimulation approach"

Katharina Klink, UPD APP Bern, Switzerland
"Targeting hippocampal hyperactivity in mild cognitive impairment with real-time fMRI neurofeedback"

Friday May 24 at 13-14

TBD

Friday June 14 at 13-14

TBD

Seminars, fall 2023

August 25 at 1 pm

Milan Němý, Czech Technical University, Czech Republic and KI
"Basal Forebrain, Cholinergic White Matter Pathways and Cognition in Normal Aging and Alzheimer’s Disease"

Niels Okkels, Aarhus University, Denmark
"Cholinergic changes in the brain and abdominal organs in dementia with Lewy bodies"

September 29 at 10 am (please not the time!)

Lyduine Collij, Lund University
"Disease heterogeneity in Alzheimer’s disease: spatial-temporal subtypes in amyloid pathology based on PET imaging"

Emma Luckett, Karolinska Institutet
"Weighted gene co-expression network analysis detects changes in the peripheral blood transcriptome in asymptomatic Alzheimer’s disease"

October 27 at 1 pm

Jessica Samuelsson, University of Gothenburg, Sweden
"Associations between dietary patterns and dementia-related neuroimaging markers"

Laura Stankeviciute, BarcelonaBeta Brain Research Center, Spain
"Sleep in preclinical stages of Alzheimer's disease: A multimodal biomarkers approach"

November 24 at 1 pm

José Paredes Pacheco, University of Málaga, Spain
"An online platform for the Monte Carlo simulation of realistic brain PET data: SimPET"

Francisco Javier López, Fundación CIEN, Spain 
"Quantification methods of PET biomarkers in Alzheimer’s disease"

December 15 at 1 pm

13.00 to 14.00, Stockholm time zone, online seminar on zoom:

Luigi Lorenzini, Amsterdam UMC, The Nederlands
"Interaction of amyloid and vascular factors in preclinical stages of Alzheimer's disease"

Marco Düring, University of Basel, Switzerland
"Neuroimaging standards for research into small vessel disease – STRIVE-2"

Seminars, spring 2023

February 24 at 1 pm

Mona-Lisa Malarte, KI
"Deciphering the interplay between reactive astrogliosis and tau pathology in 4R tauopathies"

Kevin Oliveira Hauer, Lunds universitet
"Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy"

March 27 at 1 pm

Anna Inguanzo, KI
"MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies"

Han Soo Yoo, Yonsei University, Seoul, Korea
"Multitracer PET imaging to evaluate dementia with Lewy bodies (DLB)"

April 28 at 1 pm

Bárbara Avelar Pereira, KI
“Decoding the heterogeneity of Alzheimer’s disease diagnosis & progression using multilayer networks”

Anthipa Chokesuwattanaskul, Chulalongkorn University, Thailand
The architecture of abnormal reward behaviour in dementia”

May 26 at 1 pm

Miriam Scarpa, KI
“Pre-clinical validation of SV2A-PET tracer UCB-J for detecting synaptic loss in AD and PSP”

Stephen Carter, University of Cambridge
“EMIF PreclinAD: dementia biomarkers, longitudinal cognitive trajectories and brain resilience in cognitively unimpaired elderly”

June 30 at 1 pm

Alexander Kvist, KI
"Understanding complex walking in Parkinson's disease, from gait analysis to neuroimaging"

Rodrigo Vitorio, Northumbria University
"The control of walking in Parkinson's disease: illuminating mechanisms and interventions with fNIRS"

Seminars 2022

December 16 at 1 pm

Annemieke ter Telgte, VASCage, Austria 
“On the origin of cerebral small vessel disease”

November 25 at 1 pm

Annegret Habich, KI
(Dis-)connected Dots in Dementia with Lewy Bodies – A Systematic Review of Connectivity Studies

Ramtin Mehraram, KU Leuven, Belgium
Lewy body dementia: EEG-network biomarkers and visual hallucinations

October 28 at 1 pm

Anna Dewenter, Institute for Stroke and Dementia Research
The effects of Alzheimer’s disease and cerebral small vessel disease on white matter fiber tracts

Nira Cedres, University Fernando Pessoa-Canarias
Association between cerebrovascular and Alzheimer's disease biomarkers and the degeneration of the cholinergic system

September 30 at 1 pm

Yuanjing Li, KI
Thalamic gray matter volume mediates the association between KIBRA polymorphism and olfactory function among older adults

Olof Lindberg, KI
Reduced blood oxygen dependent signal in the anterior cingulate cortex and the anterior insula in behavioral variant frontotemporal dementia when viewing images of hands in painful situations

August 26 at 1 pm

Marco Bucci, KI
Levels of plasma neurofilament light alone or in combination with pTau-181 predict for steeper cognitive decline in Typical AD and Hippocampal-sparing subtype but not in Limbic-predominant AD subtype

Konstantinos Chiotis, KI
Tracking reactive astrocytes in autosomal dominant Alzheimer’s disease with plasma GFAP and multi-modal PET

June 24 at 1 pm

Goran Papenberg, KI
Aging-related losses in fronto-striatal dopamine D2 receptor availability is linked to working-memory decline across five years

Alireza Salami, KI and Umeå University
Bi-phasic patterns of age-related differences in dopamine D1 receptors across the adult lifespan

May 27, at 1 pm

Einar August Høgestøl, University of Oslo
The brain age paradigm across neurodegenerative disorders

Daniel Vereb, KI
Directed connectivity networks across Alzheimer’s disease spectrum

April 29 at 1 pm

Laia Montoliu-Gaya, University of Gothenburg
Plasma and cerebrospinal fluid GFAP levels in Down syndrome and sporadic Alzheimer’s disease: a cross-sectional study

Bruno Robalo, University of Utrecht
Diffusion MRI harmonization enables joint-analysis of multicenter data of patients with cerebral small vessel disease

March 22 at 1 pm

Silvia Fanton, KI
NetPlotBrain: A Python package to easily create 3D network visualizations on a brain and its usage in pain neuroimaging

Didac Vidal Pineiro, University of Oslo
ggseg: visualization of brain statistics in R and applications in lifespan cognitive neuroscience

February 25 at 1 pm

Robin Pedersen, Umeå University
Inter-regional dopamine D1 co-variability reflects functional brain architecture

Jonatan Gustavsson, KI
Brain iron and the dopaminergic system: Links to cognition in aging

January 28 at 1 pm

Anna Canal García, KI
Multiplex connectome changes across the Alzheimer’s disease spectrum using gray matter and amyloid data

Mite Mijalkov, KI
Directed brain connectivity identifies widespread functional network changes in Parkinson’s disease

Contact